DNA damage in cytoskeletal protein variant-induced atrial fibrillation: A guide to novel treatment and screening targets (DnAFiX)
2022 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
DNA damage in cytoskeletal protein variant-induced atrial fibrillation: A guide to novel treatment and screening targets (DnAFiX)
van Wijk, S.; Ramos, K.; Su, W.; Liukute, A.; van Tintelen, P.; Tijsen, A. & Kirby, T. et al. (2022)
Journal of Molecular and Cellular Cardiology, 173 pp. 20. DOI: https://doi.org/10.1016/j.yjmcc.2022.08.041
